NO20021001L - Radiofarmasöytiske produkter og fremgangsmåter for fremstilling derav - Google Patents

Radiofarmasöytiske produkter og fremgangsmåter for fremstilling derav

Info

Publication number
NO20021001L
NO20021001L NO20021001A NO20021001A NO20021001L NO 20021001 L NO20021001 L NO 20021001L NO 20021001 A NO20021001 A NO 20021001A NO 20021001 A NO20021001 A NO 20021001A NO 20021001 L NO20021001 L NO 20021001L
Authority
NO
Norway
Prior art keywords
products
processes
preparation
radiopharmaceutical products
radiopharmaceutical
Prior art date
Application number
NO20021001A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021001D0 (no
Inventor
Emmanuel Bellande
Pierre Jallet
Benoit Denizot
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20021001D0 publication Critical patent/NO20021001D0/no
Publication of NO20021001L publication Critical patent/NO20021001L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/06Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20021001A 1999-09-01 2002-02-28 Radiofarmasöytiske produkter og fremgangsmåter for fremstilling derav NO20021001L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910970A FR2797769B1 (fr) 1999-09-01 1999-09-01 Produits radiopharmaceutiques et leur procede de preparation
PCT/IB2000/001161 WO2001015746A1 (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure

Publications (2)

Publication Number Publication Date
NO20021001D0 NO20021001D0 (no) 2002-02-28
NO20021001L true NO20021001L (no) 2002-04-11

Family

ID=9549465

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021001A NO20021001L (no) 1999-09-01 2002-02-28 Radiofarmasöytiske produkter og fremgangsmåter for fremstilling derav

Country Status (23)

Country Link
EP (1) EP1210127A1 (pl)
JP (1) JP2003508455A (pl)
KR (1) KR20020040799A (pl)
CN (1) CN1371292A (pl)
AU (1) AU6463100A (pl)
BG (1) BG106438A (pl)
BR (1) BR0013729A (pl)
CA (1) CA2383517A1 (pl)
CZ (1) CZ2002782A3 (pl)
EA (1) EA200200307A1 (pl)
EE (1) EE200200105A (pl)
FR (1) FR2797769B1 (pl)
HK (1) HK1044893A1 (pl)
HU (1) HUP0202714A2 (pl)
IL (1) IL148076A0 (pl)
MX (1) MXPA02001923A (pl)
NO (1) NO20021001L (pl)
NZ (1) NZ517377A (pl)
PL (1) PL353803A1 (pl)
SK (1) SK2772002A3 (pl)
WO (1) WO2001015746A1 (pl)
YU (1) YU14202A (pl)
ZA (1) ZA200201057B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094369B2 (en) 2002-03-29 2006-08-22 Scimed Life Systems, Inc. Processes for manufacturing polymeric microspheres
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7131997B2 (en) 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7053134B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7449236B2 (en) 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7588825B2 (en) 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
FR2919189A1 (fr) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres.
CN102977174B (zh) * 2012-12-19 2015-04-22 北京师范大学 99mTc(CO)3核标记大环多胺三唑环类葡萄糖基配合物及制备方法和应用
PL240772B1 (pl) 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Sposób wytwarzania nanocząstek polimerowych chelatujących izotopy promieniotwórcze do zastosowania w diagnostyce i terapii

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7412164L (sv) * 1974-09-27 1976-03-29 Pharmacia Ab Medel for intravaskuler administrering
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
WO1994005203A1 (en) * 1992-09-04 1994-03-17 The General Hospital Corporation Biocompatible polymers containing diagnostic or therapeutic moieties
US5958372A (en) * 1994-06-28 1999-09-28 Nycomed Imaging As Low viscosity chelating polymers for diagnostic imaging
FR2736834B1 (fr) * 1995-07-17 1997-08-29 Cis Bio Int Produits radiopharmaceutiques a tropisme cardiaque comportant un complexe nitruro d'un metal de transition et ayant une clairance myocardique rapide

Also Published As

Publication number Publication date
FR2797769A1 (fr) 2001-03-02
FR2797769B1 (fr) 2003-07-25
CN1371292A (zh) 2002-09-25
KR20020040799A (ko) 2002-05-30
EA200200307A1 (ru) 2002-08-29
WO2001015746A1 (en) 2001-03-08
JP2003508455A (ja) 2003-03-04
NZ517377A (en) 2003-08-29
AU6463100A (en) 2001-03-26
CZ2002782A3 (cs) 2002-08-14
PL353803A1 (pl) 2003-12-01
EP1210127A1 (en) 2002-06-05
HK1044893A1 (zh) 2002-11-08
CA2383517A1 (en) 2001-03-08
ZA200201057B (en) 2003-07-30
IL148076A0 (en) 2002-09-12
SK2772002A3 (en) 2002-09-10
NO20021001D0 (no) 2002-02-28
HUP0202714A2 (en) 2002-12-28
MXPA02001923A (es) 2003-07-21
YU14202A (sh) 2004-09-03
BR0013729A (pt) 2002-05-07
EE200200105A (et) 2003-04-15
BG106438A (bg) 2002-09-30

Similar Documents

Publication Publication Date Title
YU14202A (sh) Radiofarmaceutski proizvodi i postupak za njihovo pripremanje
HUP9902409A2 (hu) Cisztein proteáz inhibitorok
DK0687253T3 (da) Hidtil ukendte 4-aminopyridiner, fremgangsmåde til deres fremstilling samt lægemidler indeholdende disse forbindelser
TR200002606T2 (tr) Benzen-sülfonamit türevleri ve ilaç olarak kullanımları.
DE3853415D1 (de) Makrocyclische Chelatisierungsmittel und daraus hergestellte Chelate.
NO812355L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater
YU86601A (sh) Derivati purina, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
DK155828C (da) (5e)-13,14,18,18,19,19-hexadehydro-3-oxa-6a-carba-prostaglandin-i2-derivater og laegemiddel indeholdende disse
HUP9801072A2 (hu) Szubsztituált 6-és 7-amino-tetrahidro-izokinolin-karbonsav-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
ATE297918T1 (de) Tetrahydropyridine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
JPS57106695A (en) Anthracycline g lycoside compound
DK157489C (da) N-substituerede pyridiniumforbindelser og farmaceutiske praeparater indeholdende disse
DE69725133D1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
ATE78032T1 (de) 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES8306481A1 (es) Procedimiento para la obtencion de sulfamidas anulares.
DK73289A (da) Basisk substituerede 5-halogen-thienoisothiazol-3(2h)-on-1,1-dioxider, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
DK578785A (da) 9-halogen-prostanderivater og fremgangsmaade til fremstilling deraf
GB995256A (en) Quaternary ammonium salts having anti-arrhythmic activity
DE60011473D1 (de) Diazepinecarboxamidderivate, verfahren zu ihrer herstellung ,ihre verwendung als arzneimittel, pharmazeutische zubereitungen und ihre verwendung
BR9912266B1 (pt) composto derivado da 6-desàxi eritromicina, bem como medicamentos e composiÇÕes farmacÊuticas contendo os mesmos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application